[{"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; FOLIC ACID, Tablet, 1 mg may be potentially mislabeled as    OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD32328_5, EXP: 5/9/2014;  DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: W003821, EXP: 6/27/2014;  ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: W003096, EXP: 6/13/2014.", "address_2": "", "product_quantity": "1,000 Tablets", "code_info": "FOLIC ACID, Tablet, 1 mg has the following codes    Pedigree: AD33897_22, EXP: 5/9/2014;  Pedigree: W003822, EXP: 6/27/2014;  Pedigree: W003097, EXP: 6/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FOLIC ACID, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162036110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-706-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "43 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03162015@6, 6/14/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 40 mg/ml + Bupivacaine 8 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1601-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77959", "recalling_firm": "Bella Pharmaceuticals, Inc.", "address_1": "3101 W Devon Ave", "address_2": "N/A", "postal_code": "60659-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within USA", "recall_number": "D-1153-2017", "product_description": "Magnesium Chloride 200mg, 30m L vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.", "product_quantity": "5 vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20170815", "center_classification_date": "20170912", "termination_date": "20180423", "report_date": "20170920", "code_info": "Lot #: BPMC08517, Exp. 2/5/18"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090589"], "brand_name": ["EPINEPHRINE"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5985", "0093-5986"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "1870207"], "spl_id": ["f96bd477-2239-4453-aaa4-e20d16c6e49e"], "spl_set_id": ["04f07f15-55e2-411b-abb8-07eab37f5664"], "package_ndc": ["0093-5986-19", "0093-5986-27", "0093-5985-19", "0093-5985-27"], "is_original_packager": [true], "upc": ["0300935985275", "0300935986272"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0578-2021", "product_description": "EPINEPHRINE INJECTION USP, 0.15 MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS)  2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5985-27", "product_quantity": "1776 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "025C20AA"}, {"status": "Completed", "city": "Langhorne", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93449", "recalling_firm": "Insight Pharmaceuticals Corporation", "address_1": "1170 Wheeler Way Ste 150", "address_2": "N/A", "postal_code": "19047-3250", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0151-2024", "product_description": "TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder,  NET WT 4.5 oz (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591, UPC 363736532611.", "product_quantity": "117,336 cans", "reason_for_recall": "Chemical Contamination; presence of benzene.", "recall_initiation_date": "20231122", "center_classification_date": "20231215", "report_date": "20231227", "code_info": "Lot #s: 0H88645, Exp 07/31/2024; 0B88345, Exp 02/29/2024."}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0498-2022", "product_description": "Regular Strength Pain Reliever (acetaminophen 110 mg, aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) 2 tablet packets, Mfg for Advanced First Aid, Baltimore, MD 21237, NDC 67060-0113-00", "product_quantity": "1,180,000 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9450, Exp. Date 01/2022"}, {"status": "Terminated", "city": "East Hanover", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA208073"], "brand_name": ["XIIDRA"], "generic_name": ["LIFITEGRAST"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0911"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["LIFITEGRAST"], "rxcui": ["1801835", "1801840"], "spl_id": ["3cabbaea-c2bf-971c-e063-6394a90a4931"], "spl_set_id": ["8589d376-ac10-4ddb-9c53-2e0c8d5675c4"], "package_ndc": ["0078-0911-05", "0078-0911-12", "0078-0911-95", "0078-0911-94"], "is_original_packager": [true], "nui": ["N0000192701", "N0000192700"], "pharm_class_epc": ["Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]"], "pharm_class_moa": ["Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]"], "unii": ["038E5L962W"]}, "product_type": "Drugs", "event_id": "90176", "recalling_firm": "Novartis Pharmaceuticals Corporation", "address_1": "1 Health Plz", "address_2": "", "postal_code": "07936-1016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0982-2022", "product_description": "Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-12) and b) 5- Single-Use Containers (NDC 0078-0911-05) Rx Only, Manufactured by: The Ritedose Corporation, Columbia, SC 29203, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936.", "product_quantity": "1,187,092 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20220510", "center_classification_date": "20220606", "termination_date": "20240228", "report_date": "20220615", "code_info": "Lot #:a) and b) 20E21, 20E22, 20E53, 20E54, 20E95, 20E96, 20ED1, 20ED2, 20ED3, 20EK1 Exp. Date 4/2023; 20F27, 20F28, 20F66, 20F67,20FH6, Exp. Date 05/2023; 20G47, 20G48, 20G49, 20G57, 20GB8,  20GE5, 20GE6, Exp. Date 06/2023; 20M41, 20M42, 20M56, 20M66,  20M67, 20MA4, Exp. Date 07/2023; 20S20, 20S22, 20S44, 20S94, Exp. Date 10/2023; 20SA6, 20SA7, 20SE0, Exp. Date 10/2023, 20TE2, 20TG5, Exp. Date 11/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0528-2017", "product_description": "MINOXADIL all strength including 2%, 5% and MINOXIDIL / RETINOIC ACID 5% / 0.025, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91263", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two different customers in MI.", "recall_number": "D-0077-2023", "product_description": "Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ  08816; Repackaged by: RemedyRepack Inc., Indiana, PA  15701, NDC #: 70518-3493-00.", "product_quantity": "9 boxes", "reason_for_recall": "Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.", "recall_initiation_date": "20221205", "center_classification_date": "20221207", "termination_date": "20230203", "report_date": "20221214", "code_info": "Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0684-2022", "product_description": "Fluocinonide Gel USP, 0.05%, packaged in a) 15 g tubes, NDC 52565-054-15; b) 60 g tubes, NDC 52565-054-60; c) 30 g tubes, NDC 52565-054-30, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310.", "product_quantity": "51,748 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15122, Exp. 2/28/2022; 15475, Exp. 3/31/2022; b) 15119, Exp. 2/28/2022; 15122, Exp. 2/28/2022; 15380, Exp. 3/31/2022; c) 15380, Exp. 3/31/2022"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-856-2015", "product_description": "Prednisolone Anhydrous active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "31800 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85239", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1258-2020", "product_description": "Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02", "product_quantity": "15,170 ampules", "reason_for_recall": "Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.", "recall_initiation_date": "20200325", "center_classification_date": "20200501", "termination_date": "20220728", "report_date": "20200408", "code_info": "Lot 081887A, EXP 08/2021"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA091383"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-687"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LORAZEPAM"], "rxcui": ["311376"], "spl_id": ["99b5d0cb-3d61-497c-9b51-7d0939f923a0"], "spl_set_id": ["bf265c2e-ab2f-42e5-96cf-3998eb5a644d"], "package_ndc": ["65162-687-84"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "77898", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0120-2018", "product_description": "Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ 08876. Distributed by: Amneal Pharmaceuticals, Glasgow, KY 42141. NDC 65162-687-84", "product_quantity": "136376 bottles", "reason_for_recall": "Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.", "recall_initiation_date": "20170803", "center_classification_date": "20171220", "termination_date": "20220907", "report_date": "20171227", "code_info": "Lot 06876016A, 06876017A, 06876018A, Exp 08/2018; 06876019A, 06876020A, 06876021A, 06876022A, Exp 09/2018; 06876023A, Exp 11/2018;  06876024A, 06876025A, Exp 12/2018; 06877001A, 06877002A, Exp 02/2019;  06877003A, Exp 03/2019.", "more_code_info": ""}, {"status": "Ongoing", "city": "Yunlin County", "state": "", "country": "Taiwan", "classification": "Class III", "openfda": {"application_number": ["ANDA205932"], "brand_name": ["PITAVASTATIN"], "generic_name": ["PITAVASTATIN CALCIUM"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "product_ndc": ["0480-3631", "0480-3632", "0480-3633"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PITAVASTATIN CALCIUM"], "rxcui": ["861643", "861648", "861652"], "spl_id": ["191b4856-1662-a7b8-e063-6394a90a2c56"], "spl_set_id": ["fac09182-dcf2-1770-e053-6394a90af50c"], "package_ndc": ["0480-3632-98", "0480-3633-98", "0480-3631-98"], "is_original_packager": [true], "upc": ["0304803633985", "0304803631981", "0304803632988"], "unii": ["IYD54XEG3W"]}, "product_type": "Drugs", "event_id": "97076", "recalling_firm": "Orient Pharma Co., Ltd. Yunlin Plant", "address_1": "No. 8 Kehu 1st Rd.", "address_2": "Huwei Township", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-0526-2025", "product_description": "Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3632-98.", "product_quantity": "57504 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20250611", "center_classification_date": "20250716", "report_date": "20250709", "code_info": "P061001, P061002, P061003, P061004, P061006 & P061007 Exp Date 07/2025; P061008, Exp Date 08/2025; P061009 & P061010 Exp Date 10/2025; P061011, P061012 & P061013 Exp Date 01/2026; P061016, P061017 & P061018, Exp Date 04/2026; P061019, Exp Date 05/2026; P061023, Exp Date 01/2027.", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1606-2019", "product_description": "Lump Off Capsules, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0255-2024", "product_description": "Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Lavender, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-383-10, UPC: 0 37000 72986 0", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "10 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "testosterone cypionate, 100 mg/mL, 10 mL unit size, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0717-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bangalore", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA065421"], "brand_name": ["RIFAMPIN"], "generic_name": ["RIFAMPIN"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["RIFAMPIN"], "rxcui": ["312821"], "spl_id": ["f1107e3c-754b-407d-9d66-23f545c0c692"], "spl_set_id": ["8be91604-d7cd-4f2b-997d-e3364e4092e5"], "package_ndc": ["67457-445-60"], "is_original_packager": [true], "nui": ["N0000175500", "M0019113"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "pharm_class_cs": ["Rifamycins [CS]"], "unii": ["VJT6J7R4TR"]}, "product_type": "Drugs", "event_id": "83914", "recalling_firm": "Mylan Laboratories Limited (Sterile Products Division)", "address_1": "Opp. Iim-B, Bilekahalli , Bannerghatta Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0139-2020", "product_description": "Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for:  Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.", "product_quantity": "19,165 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.", "recall_initiation_date": "20191007", "center_classification_date": "20191010", "termination_date": "20230309", "report_date": "20191016", "code_info": "Lot: 7008334, Exp April 2020; 7008417, Exp Oct 2020"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0732-2023", "product_description": "heparin added to 0.9% sodium chloride, 5,000 units/500 mL* (10 units/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-7023-1.", "product_quantity": "5207 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-888736, 37-888769, Exp 05/02/2023; 37-890465, 37-890483, Exp 05/09/2023; 37-892088, 37-892117, 37-892119, 37-892145, Exp 05/16/2023; 37-893759, 37-893765, Exp 05/23/2023; 37-895742, 37-895751, Exp 05/30/2023"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81458", "recalling_firm": "Sciegen Pharmaceuticals Inc", "address_1": "89 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0269-2019", "product_description": "Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69367-121-03), Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755.  Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA.", "product_quantity": "5,989 HDPE", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181029", "center_classification_date": "20181120", "termination_date": "20230925", "report_date": "20181128", "code_info": "69367-121-01 Irbesartan 300mg Tablets, 30 count bottle B162008A Sep-19   C162002A Feb-20   69367-121-03 Irbesartan 300mg Tablets, 90 count bottle B162008B Sep-19   C162002B Feb-20", "more_code_info": ""}, {"country": "United States", "city": "Peapack", "address_1": "100 Route 206 North", "reason_for_recall": "Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.", "address_2": "", "product_quantity": "4848 bottles", "code_info": "Lot #: V121211, Exp 03/31/2017", "center_classification_date": "20131120", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NJ", "product_description": "Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5012-1", "report_date": "20131127", "classification": "Class II", "openfda": {}, "recalling_firm": "Greenstone Llc", "recall_number": "D-011-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66822", "termination_date": "20170413", "more_code_info": "", "recall_initiation_date": "20130904", "postal_code": "07977", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Randolph", "address_1": "540 Route Ten West", "reason_for_recall": "Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.", "address_2": "", "product_quantity": "50 bottles", "code_info": "Lot #: 05202014@3, Exp 11/16/2014", "center_classification_date": "20141219", "distribution_pattern": "Directly to patients and physicians in FL, NJ, NY, and Puerto Rico", "state": "NJ", "product_description": "Tropi/Cyclo/Phenyl/Tobra/Flurb (1/1/10/0.3/0.03)% Sterile Ophthalmic Solution, 1 mL Dropper in a 3 mL bottle, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.", "report_date": "20141231", "classification": "Class I", "openfda": {}, "recalling_firm": "Pharmacy Creations", "recall_number": "D-0308-2015", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "69184", "termination_date": "20150706", "more_code_info": "", "recall_initiation_date": "20140905", "postal_code": "07869", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1261-2022", "product_description": "Ketamine HCl Injection, USP, 50 mg/1 mL (50 mg/mL*) syringe, packaged in 5 x 1 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-511-01", "product_quantity": "47,905 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: KH2009A, Exp. 8/16/2022; KH2011A, Exp. 8/24/2022; KH2013A, Exp. 8/28/2022; KH2014A, Exp. 9/9/2022; KH2018A, Exp. 10/7/2022; KH2020A, Exp. 10/18/2022"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81120", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Hawaii and Puerto Rico.", "recall_number": "D-0244-2019", "product_description": "Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02", "product_quantity": "1,362 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing", "recall_initiation_date": "20180927", "center_classification_date": "20181114", "termination_date": "20201006", "report_date": "20181121", "code_info": "Lot # 31323147B, exp. date 01/2019", "more_code_info": ""}, {"country": "United States", "city": "Pleasanton", "address_1": "39 California Ave Ste 104", "reason_for_recall": "Labeling: Not Elsewhere Classified:  due to a labeled declaration of; Store at 15\u00bfC to 30\u00bfC (59\u00bfF to 86\u00bfF) which differs from the original manufacturer declaration of; Store at 20\u00bfC to 25\u00bfC (68\u00bfF to 77\u00bfF).", "address_2": "", "product_quantity": "5 28-count containers", "code_info": "Lot # 0130132, EXP 3/31/19", "center_classification_date": "20180514", "distribution_pattern": "California.", "state": "CA", "product_description": "Clindamycin 300 mg capsules, USP, 28-count M-Pak containers, Rx Only. Mnfct for: Lannett Co. Inc., Philadelphia, PA 19136. Mnfct. by: Lannett Co. Inc., Philadelphia, PA 19136. Pckgd by PreScript Pharm. Inc., Pleasanton, CA 94566. NDC: 00527-1383-01, Bar Code 0784-28-11", "report_date": "20180523", "classification": "Class II", "openfda": {}, "recalling_firm": "Prescript Pharmaceuticals, Inc.", "recall_number": "D-0808-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79961", "termination_date": "20190123", "more_code_info": "", "recall_initiation_date": "20180424", "postal_code": "94566-6279", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "11 vials (10 mL each)", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Progesterone in Olive Oil Injectable  Balanced Solutions, Compounding Pharmacy a division ofAxium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-277-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73018", "recalling_firm": "R Thomas Marketing, LLC", "address_1": "3704 White Plains Rd", "address_2": "N/A", "postal_code": "10467-5710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via Internet sales", "recall_number": "D-0884-2016", "product_description": "Black Ant, packaged in Big Box (20 small boxes / 4 capsules per box / 80 capsules total), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA", "recall_initiation_date": "20160109", "center_classification_date": "20160526", "termination_date": "20190621", "report_date": "20160601", "code_info": "all lots"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0548-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Sinus Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955513421, NDC 57955-5134-2", "product_quantity": "16184 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 032217D Exp. 03/20; 033116B Exp. 03/19; 041518F Exp. 04/20; 061715D Exp. 06/18; 080116C Exp. 08/19; 100417A Exp. 10/19; 121916A Exp. 12/19"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-590-2015", "product_description": "Cisplatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "34 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0065-2015", "product_description": "Calcium chloride (PF) 100 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "110 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08072014@61, Exp 9/6/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74742", "recalling_firm": "GlaxoSmithKline, LLC", "address_1": "1011 N Arendell Ave", "address_2": "N/A", "postal_code": "27597-2309", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR.", "recall_number": "D-1444-2016", "product_description": "Bactroban Nasal, (Mupirocin Calcium Ointment 2%), 1 gram Single Use Tubes, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0029-1526-11.", "product_quantity": "153,119 tubes", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20160718", "center_classification_date": "20160720", "termination_date": "20170809", "report_date": "20160727", "code_info": "Lot #: C686801, C689267, C692405, Exp. Jul 2016;  C698116, Exp. Sep 2016;  C750793, C750794, C752166, C752805 and C754828, Exp. Nov 2017.", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0476-2020", "product_description": "CVS Health Preservative Free Lubricant Gel Drops Dry Eye Relief, Item#: 634634, Product Size: 0.6 mL x 30, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895", "product_quantity": "114504 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "SEI 5/20   TAK 01/21"}, {"status": "Terminated", "city": "San Luis Obispo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84284", "recalling_firm": "Integrated Health Concepts Inc. dba Conversio Health", "address_1": "720 Aerovista Pl Ste D", "address_2": "N/A", "postal_code": "93401-8726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0513-2020", "product_description": "Albuterol 2.5mg / Budesonide 0.5mg, 3ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis Obispo, CA 93401.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20191112", "center_classification_date": "20191119", "termination_date": "20200528", "report_date": "20191127", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0211-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 20 INJ **T 104**  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "22 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07192021:23 BUD: 01/15/2022; 08032021:21 BUD: 01/30/2022; 04282021:39 BUD: 10/23/2022; 06102021:69 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Foster City", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67557", "recalling_firm": "Gilead Sciences, Inc.", "address_1": "333 Lakeside Dr", "address_2": "", "postal_code": "94404-1147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide including Puerto Rico.", "recall_number": "D-1090-2014", "product_description": "Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only.  Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404.  Made in Ireland. NDC 15584-0101-1.    Manufactured for:  Bristol-Myers-Squibb & Gilead Sciences, LLC,  Foster City, CA 94404  Made in Ireland", "product_quantity": "39,223 bottles", "reason_for_recall": "Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.", "recall_initiation_date": "20140219", "center_classification_date": "20140227", "termination_date": "20150511", "report_date": "20140305", "code_info": "Lot #'s: 002390, 002400, Exp 02/17.", "more_code_info": ""}, {"country": "United States", "city": "Gaithersburg", "address_1": "9841 Washingtonian Blvd Ste 500", "reason_for_recall": "Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.", "address_2": "", "product_quantity": "7479 vials", "code_info": "Lot# 3012A, 3013A, 30138,  Exp. 11/13  Lot# 3014A, 3014A CLIN, Exp. 12/13", "center_classification_date": "20140115", "distribution_pattern": "Nationwide", "state": "MD", "product_description": "PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial, Rx ONLY, sigma-tau PHARMACEUTICALS INC, 9841 Washingtonian Blvd, Gaithersburg, MD 20878 NDC 54482-301-01", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Sigma-Tau Pharmaceuticals, Inc.", "recall_number": "D-736-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66741", "termination_date": "20141218", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "20878-1978", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0182-2015", "product_description": "CHORIONIC GONADOTROPIN, 5000 Units, sterile powder for reconstitution, glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "117 vials", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #:  20140909@5, discard date: 3/8/2015;  Lot #:  20140728@57, discard date: 1/14/2015."}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83417", "recalling_firm": "Medtech Products, Inc.", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.", "recall_number": "D-1824-2019", "product_description": "Clear eyes MAXIMUM ITCHY EYE RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%, Zinc Sulfate 0.25%) eye drops, 0.5 FL OZ (15 mL) bottle, Distributed by Medtech Products Inc., Tarrytown, NY  10591, A Prestige Brands Company, UPC 6 78112 65920 3.", "product_quantity": "927,108 bottles", "reason_for_recall": "CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.", "recall_initiation_date": "20190726", "center_classification_date": "20190816", "termination_date": "20210310", "report_date": "20190828", "code_info": "Lot #: 16302, Exp 11/19; 16331, 16344, Exp 12/19; 17011, 17016, Exp 01/20."}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-673-2013", "product_description": "Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "12ml", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCCHBB:81, Exp date: 5/26/2013."}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-261-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles ( NDC 60793-860-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "14464 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a) 66671B, Exp. 11/13; 67512B, Exp. 02/14 b) 66739B Exp. 11/13; 67513B Exp. 02/14"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "75146", "recalling_firm": "VIRTUS PHARMACEUTICALS OPCO II L", "address_1": "1321 Murfreesboro Pike #", "address_2": "N/A", "postal_code": "37217-2726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0214-2017", "product_description": "Hyoscyamine Sulfate, USP Tablets, 0.125 mg, 100-count tablets per bottle, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC., Nashville, TN  37217, NDC 76439-308-10.", "product_quantity": "24,444 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.", "recall_initiation_date": "20160902", "center_classification_date": "20161222", "termination_date": "20190923", "report_date": "20161228", "code_info": "Lot #: 30031601, 30031602, Exp 01/18"}, {"status": "Terminated", "city": "Polepally, Jadcherla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA208302"], "brand_name": ["IMATINIB MESYLATE"], "generic_name": ["IMATINIB MESYLATE"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "product_ndc": ["72485-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IMATINIB MESYLATE"], "rxcui": ["403878"], "spl_id": ["f3d17411-8424-4c6d-b244-47f125f17f31"], "spl_set_id": ["2e931c49-6c9f-41e2-a34b-5f01cd295b56"], "package_ndc": ["72485-202-90"], "is_original_packager": [true], "unii": ["8A1O1M485B"]}, "product_type": "Drugs", "event_id": "86749", "recalling_firm": "Shilpa Medicare Limited", "address_1": "S-20 To S-26,  Pharm. Formulation Sez", "address_2": "Tsiic, Green Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0124-2021", "product_description": "Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90.", "product_quantity": "2611 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201208", "center_classification_date": "20201209", "termination_date": "20220311", "report_date": "20201216", "code_info": "Lot #s: 7S10033B, 7S10033A, 7S10031A, Exp. 02/28/2021."}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0201-2016", "product_description": "BIEST TD 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3) : PROG (Progesterone USP Micronized) : DHEA (Dehydroepiandrosterone Micronized) : TESTO (Testosterone Trit) W/V (weight/volume) VERSABASE 6.5 : 30: 1.25: 0.25  MG/ML Transdermal cream, dispensed in 10 mL prefilled, amber syringes, Rx only,  The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "12 (10mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 01232015:52@49, Exp 7/22/2015"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017427"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0048"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["123eac3f-8e50-4689-bf00-cf9407eb70ee"], "spl_set_id": ["b3b4b176-41f0-4ca8-90d4-3fba5707564a"], "package_ndc": ["0338-0048-02", "0338-0048-03", "0338-0048-04", "0338-0048-05"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "67974", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-1282-2014", "product_description": "0.9% Sodium Chloride Irrigation, USP, 1000 mL,Not for Injection,  Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0048-04.", "product_quantity": "211,752 bottles", "reason_for_recall": "Presence of Particulate Matter: Nylon fibers found in a bottle of 0.9% sodium chloride for irrigation.", "recall_initiation_date": "20140421", "center_classification_date": "20140428", "termination_date": "20150224", "report_date": "20140507", "code_info": "Lot # Gl09272; Exp 09/16", "more_code_info": ""}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "10 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: t07312013@28", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Polidocanol, 3% injectable, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-440-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0637-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Snore Control, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955512028, NDC 57955-5120-2", "product_quantity": "14781 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 052516Y Exp. 05/19; 060518C Exp. 06/20; 060917F Exp. 06/19; 070518A Exp. 07/20; 080317C Exp. 08/19; 081015B Exp. 08/18; 081815G Exp. 08/18; 111516C Exp. 11/19; 112317E Exp. 11/19"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-115-2013", "product_description": "Clonidine 100 mcg/mL PF, 1mL and 2 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "2747 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA070434"], "brand_name": ["FUROSEMIDE"], "generic_name": ["FUROSEMIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0054-3294", "0054-4297", "0054-8297", "0054-4299", "0054-8299", "0054-4301", "0054-8301", "0054-3298"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FUROSEMIDE"], "rxcui": ["197730", "197731", "197732", "310429", "313988"], "spl_id": ["bae23091-065c-4127-a363-16d15dce1c5c"], "spl_set_id": ["9e493331-dddd-496e-abf8-61747fb67aba"], "package_ndc": ["0054-4297-31", "0054-4297-25", "0054-8297-25", "0054-4299-31", "0054-4299-25", "0054-8299-25", "0054-4301-29", "0054-4301-25", "0054-8301-25", "0054-3298-63", "0054-3294-50", "0054-3294-46"], "is_original_packager": [true], "upc": ["0300544301251", "0300544299251", "0300544297257", "0300543298637", "300544299312"], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["7LXU5N7ZO5"]}, "product_type": "Drugs", "event_id": "72234", "recalling_firm": "Boehringer Ingelheim Roxane Inc", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0012-2016", "product_description": "FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4299-31, UPC 3 0054-4299-31 2.", "product_quantity": "5,160 bottles", "reason_for_recall": "CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.", "recall_initiation_date": "20150925", "center_classification_date": "20151009", "termination_date": "20160219", "report_date": "20151021", "code_info": "Lot #: 559310P, Exp 02/17; 559664B, Exp 04/17"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0059-2019", "product_description": "Best Choice, SALINE Nasal Spray (Sodium Chloride 0.65% Phenylcarbinol & Benzalkonium Chloride as Preservatives), 1.5 FL OZ (44 mL) bottle, Proudly Distributed By: Valu Merchandisers, Co., 5000 Kansas Ave, Kansas City, KS 66106, UPC 0 70038 58487 2.", "product_quantity": "30,096 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0045-2023", "product_description": "PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 90MG/3MG/29.4MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 66450, BUD: 11/07/2022; 66527, BUD: 11/09/2022"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA073135"], "brand_name": ["METOCLOPRAMIDE"], "generic_name": ["METOCLOPRAMIDE"], "manufacturer_name": ["Teva Parenteral Medicines, Inc."], "product_ndc": ["0703-4502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METOCLOPRAMIDE HYDROCHLORIDE"], "rxcui": ["311670"], "spl_id": ["e640a87c-7ee3-4ca2-9808-3916bfd1a54b"], "spl_set_id": ["cccf04bd-7463-40b8-a41f-cb1093c358d7"], "package_ndc": ["0703-4502-01", "0703-4502-04"], "is_original_packager": [true], "unii": ["W1792A2RVD"]}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0741-2021", "product_description": "Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-4502-01", "product_quantity": "25,653 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31326043B, exp. date 10/2021;  31326138B, exp. date 11/2021  31329399B, 31329539B, exp. date 08/2023; 31329599B, exp. date 09/2023"}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202544"], "brand_name": ["TELMISARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["TELMISARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-840", "68462-841", "68462-842"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "TELMISARTAN"], "rxcui": ["283316", "283317", "477130"], "spl_id": ["ed501261-5e53-41fe-998f-98b6a0ffb719"], "spl_set_id": ["1e55800d-f77c-4950-a6d7-2055f4c7ea17"], "package_ndc": ["68462-840-13", "68462-841-13", "68462-842-13"], "is_original_packager": [true], "upc": ["0368462840139", "0368462841136", "0368462842133"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "90541", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-1306-2022", "product_description": "Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc,m USA, Mahwah, NJ 07430, NDC 68462-841-13.", "product_quantity": "", "reason_for_recall": "Defective Container: Recall of these batches has been initiated due to complaints of  difficult to open blister and tablet breaks while opening the blister .", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240627", "report_date": "20220817", "code_info": "Lots 17210929 & 17210930, Exp Date  05/2023;       Lot 17211203, Exp Date 06/2023 &     Lots 17211643, 17211646 & 17211649, Exp Date  08/2023", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; FLUCONAZOLE, Tablet, 100 mg may be potentially mislabeled as    PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003086, EXP: 6/12/2014.", "address_2": "", "product_quantity": "30 Tablets", "code_info": "FLUCONAZOLE, Tablet, 100 mg has the following code    Pedigree: W003064, EXP: 6/12/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FLUCONAZOLE, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68462010230", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-729-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078177"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-300"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807639"], "spl_id": ["26587576-d68d-4c98-e063-6394a90ac53d"], "spl_set_id": ["af5cdf1a-19f4-11e2-892e-0800200c9a66"], "package_ndc": ["49230-300-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "90997", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0015-2023", "product_description": "0.9% Sodium Chloride Injection, USP, Each 100 mL contains: SODIUM CHLORIDE, USP - 900 mg, WATER FOR INJECTION, USP - qs, 1000mL Bag, 12 PK, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-300-10", "product_quantity": "16,006 cases of twelve bags each", "reason_for_recall": "Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.", "recall_initiation_date": "20221011", "center_classification_date": "20221020", "report_date": "20221026", "code_info": "Lot # 22EU05043, EXP 5/21/2023; 22HU05018, EXP 6/9/2023; 22HU05019, EXP 6/10/2023; 22HU05025, 22HU05026, EXP 6/12/2023; 22HU05049, EXP 6/22/2023; 22HU05053, EXP 6/24/2023; 22HU05054, 22HU05055, EXP 6/25/2023; 22HU06027, EXP 6/11/2023; 22HU06049, EXP 6/23/2023; 22HU06055, EXP 6/24/2023; 22HU06056, EXP 6/25/2023; 22JU05008, EXP 7/4/2023; 22KU06036, EXP 8/19/2023; 22JU06023, EXP 7/8/2023", "more_code_info": ""}, {"country": "United States", "city": "Camarillo", "address_1": "5187 Camino Ruiz", "reason_for_recall": "Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer", "address_2": "", "product_quantity": "6158 bottles", "code_info": "Exp     NDC                        Lot #  Date     60429-046-10  69393A1  09/2015     60429-046-1 0  69395A1  09/2015     60429-046-10  69495A1  10/2015     60429-046-10  69496A1  10/2015     60429-046-01  69497A1  02/2014     60429-046-10  69524A1  10/2015     60429-046-10  69524A2  10/2015     60429-046-10  69525A1  10/2015     60429-046-10  69525A2  10/2015", "center_classification_date": "20130407", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP, 20 mg/25 mg, 100 (NDC 60429-046-01)  and 1,000 (NDC 60429-046-10) count bottles, Rx only, GSMS Inc., Camarillo, CA", "report_date": "20130417", "classification": "Class II", "openfda": {}, "recalling_firm": "Gsms", "recall_number": "D-244-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64695", "termination_date": "20130903", "more_code_info": "", "recall_initiation_date": "20130311", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1131-2020", "product_description": "Hernia Off, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205006"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "product_ndc": ["68462-678", "68462-679", "68462-680", "68462-681"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_id": ["a65056ce-b6e9-4bed-adbd-98052a2e705e"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "package_ndc": ["68462-678-30", "68462-678-60", "68462-678-10", "68462-679-30", "68462-679-60", "68462-679-10", "68462-680-30", "68462-680-60", "68462-680-10", "68462-681-30", "68462-681-60", "68462-681-10"], "is_original_packager": [true], "upc": ["0368462680605", "0368462681602"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0337-2025", "product_description": "Lacosamide Tablets, 50mg, 60-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-678-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240221, exp. date Jan-26 17240222, exp. date Jan-26"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NASAL"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["Meijer Distribution Inc"], "product_ndc": ["41250-989"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["0bba7eea-2347-46a8-aa95-9258cb589a1b"], "spl_set_id": ["ec8db98f-4fd1-4644-b76f-ff04f72e87f4"], "package_ndc": ["41250-989-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0628-2022", "product_description": "Maximum Strength Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant with Menthol, 1 FL Oz (30 mL) per bottle, DIST. BY MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544. NDC 41250-989-10", "product_quantity": "2,302 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0716, Exp 12/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73336", "recalling_firm": "Walter's Pharmacy", "address_1": "401 N 17th St", "address_2": "N/A", "postal_code": "18104-5034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "PA", "recall_number": "D-0789-2016", "product_description": "Rose Bengal 1% Ophth Solution, 5mL bottle, Rx only, Walter's Pharmacy 401 N 17th St., Allentown, PA 610-435-4706", "product_quantity": "3 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160212", "center_classification_date": "20160329", "termination_date": "20170106", "report_date": "20160406", "code_info": "Lot #: 012516"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74099", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-0949-2016", "product_description": "Sulfacetamide Sodium Ophthalmic Solution, USP, 10%, Sterile, Rx Only, 15 mL bottles, Mfd. by: Akorn, Inc., Lake Forest, IL 60045 --- NDC 17478-221-12", "product_quantity": "57,920 bottles", "reason_for_recall": "Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability", "recall_initiation_date": "20160517", "center_classification_date": "20160529", "termination_date": "20170721", "report_date": "20160608", "code_info": "Lot# 5A17A, Expiry 06/16  Lot# 5K21A, Expiry 03/17  Lot# 6A08A, Expiry 06/17"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ASPIRIN EC, Tablet, 325 mg may have potentially been mislabeled as one of the following drugs:  MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg, NDC 58914001460, Pedigree: AD30180_10, EXP: 5/9/2014;  DILTIAZEM HCL ER, Capsule, 240 mg, NDC 49884083109, Pedigree: AD52375_1, EXP: 5/17/2014;  ASPIRIN, Tablet, 325 mg, NDC 00536330501, Pedigree: W003355, EXP: 6/19/2014;  ASPIRIN, Tab", "address_2": "", "product_quantity": "499 Tablets", "code_info": "ASPIRIN EC, Tablet, 325 mg has the following codes:   Pedigree: AD30180_13, EXP: 5/9/2014;  Pedigree: AD52378_1, EXP: 5/17/2014;  Pedigree: W003356, EXP: 6/19/2014;  Pedigree: W003526, EXP: 6/21/2014;  Pedigree: AD39588_1, EXP: 5/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN EC, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201360.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1025-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0296-2020", "product_description": "S-TRIMIX (29.4MG/0.98MG/9.8MCG/ML) INJ; Rx Only, 5ml glass vial. Red Mountain Compounding Rx", "product_quantity": "3x5ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:S06092019DH@07, Exp 8/9/19; S06112019DH@03, Exp 8/11/19;S06122019DH@01, Exp 8/12/19;"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot #: 20180223@1, BUD 04/24/2018; 20180129@5, BUD 03/30/2018; 20180126@4, BUD 03/27/2018; 20180215@22, BUD 04/16/2018; 20180122@10, 20180126@4, BUD 03/23/2018; 20180202@27, BUD 04/03/2018; 20180208@5, 20180201@2, BUD 04/02/2018; # 20180207@2, BUD 04/08/2018, 20180214@11, BUD 04/15/2018; 20180215@22, BUD 04/16/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "MVI-7 (B1-100mg/B3-100mg, B5-252 mg, B6-102mg, Vit C-2500 mg, B12-10mg, Mag-1000 mg)/ vial liquid injectable, 50 mL amber vial, Rx only,  Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0656-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200268"], "brand_name": ["PIOGLITAZONE"], "generic_name": ["PIOGLITAZONE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-219", "57237-220", "57237-221"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PIOGLITAZONE HYDROCHLORIDE"], "rxcui": ["312440", "312441", "317573"], "spl_id": ["f3308268-8023-434e-8caf-734ca298b98e"], "spl_set_id": ["4483b1c6-7095-4a63-8128-ac2d91e11040"], "package_ndc": ["57237-219-30", "57237-219-90", "57237-219-05", "57237-220-30", "57237-220-90", "57237-220-05", "57237-221-30", "57237-221-90", "57237-221-05"], "is_original_packager": [true], "upc": ["0357237221303", "0357237220306", "0357237219300"], "unii": ["JQT35NPK6C"]}, "product_type": "Drugs", "event_id": "89323", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0450-2022", "product_description": "Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05", "product_quantity": "792 bottles", "reason_for_recall": "Superpotent and Failed Tablet/Capsule Specifications", "recall_initiation_date": "20211229", "center_classification_date": "20220124", "termination_date": "20231204", "report_date": "20220202", "code_info": "Batch # PF4520028B & PF4520028A, Exp. Date 11/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83200", "recalling_firm": "Geritrex, LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1521-2019", "product_description": "Ritussin DM Children & Adults, 4 Fl. Oz. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-409-04", "product_quantity": "5107 bottles", "reason_for_recall": "cGMP Deviations: Products may have microbial contamination.", "recall_initiation_date": "20190531", "center_classification_date": "20190725", "termination_date": "20240202", "report_date": "20190731", "code_info": "Lot #: 70602, Exp 6/19"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "91882", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0472-2023", "product_description": "Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC  68968-5554-3.", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: Out of specification for shear.", "recall_initiation_date": "20230310", "center_classification_date": "20230320", "report_date": "20230329", "code_info": "Lot#: 91957, 92197, Exp. 7/2023; 92476, Exp. 9/2023; 92477, Exp. 10/2023"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "C5629 Exp 10/31/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Taurine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-785-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0166-2015", "product_description": "Tri-mix T25, 4.413 mg/0.145 mg/1.475 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08122014@23, Exp 11/10/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77777", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1004-2017", "product_description": "PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride, (Final Concentration = 0.1 mg per mL), Total Volume 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR  72205 (877) 550-5059; NDC: 70004-0810-32.", "product_quantity": "2 bags", "reason_for_recall": "Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170725", "termination_date": "20191030", "report_date": "20170802", "code_info": "Lot: 20170710@3, BUD: 10/8/2017"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029297 Exp. 11/14/2019    10029199 Exp. 11/17/2019,    10029737 Exp. 11/17/2019,    10029763 Exp. 11/17/2019,    10029785 Exp. 11/18/2019,    10029789 Exp. 11/18/2019,  ,  10029790 Exp. 11/18/2019,    10029894 Exp. 11/20/2019,    10029950 Exp. 11/21/2019,    10030006 Exp. 11/24/2019,  ,  10030007 Exp. 11/27/2019,    10030336 Exp. 11/27/2019,  ,  10030941 Exp. 12/3/2019,  10030886 Exp. 12/2/2019,  10030453 Exp. 11/26/2019,    10030887 Exp. 12/4/2019,    10030990 Exp. 12/4/2019,  10030991 Exp. 12/4/2019,,  10030942 Exp. 12/3/2019,    10030886 Exp. 12/2/2019,  10030909 Exp. 12/2/2019,    10030431 Exp. 11/26/2019,    10030432 Exp. 11/26/2019,    10030454 Exp. 11/26/2019,    10031056 Exp. 12/5/2019,  10031057 Exp. 12/5/2019,    10030990 Exp. 12/4/2019,    10030886 Exp. 12/2/2019,,  10030454 Exp. 11/26/2019,  10031056 Exp. 12/5/2019,      10031058 Exp. 12/5/2019,  10031087 Exp. 12/6/2019,  10031153 Exp. 12/8/2019,  10031087 Exp. 12/6/2019,  10031088 Exp. 12/6/2019,  10031376 Exp. 12/6/2019,    10031178 Exp. 12/9/2019,    10031179 Exp. 12/9/2019,    10031152 Exp. 12/8/2019,    10031153 Exp. 12/8/2019,  10031376 Exp. 12/6/2019,  10031236 Exp. 12/10/2019,      10031179 Exp. 12/9/2019,  10031152 Exp. 12/8/2019,  10031236 Exp. 12/10/2019,  10031237 Exp. 12/10/2019,    10031732 Exp. 12/22/2019,    10031616 Exp. 12/19/2019,  10031617 Exp. 12/22/2019,    10031731 Exp. 12/22/2019,    10031732 Exp. 12/22/2019,    10031616 Exp. 12/19/2019,    10031617 Exp. 12/22/2019,    10031950 Exp. 12/26/2019,  10031979 Exp. 12/29/2019,    10031980 Exp. 12/30/2019,    10032308 Exp. 12/31/2019,    10032309 Exp. 12/31/2019,    10032415 Exp. 1/2/2020,  10032416 Exp. 1/2/2020,  10032804 Exp. 1/5/2020,    10032805 Exp. 1/5/2020,    10032582 Exp. 1/6/2020,  10032808 Exp. 1/6/2020,  10032809 Exp. 1/6/2020,    10032810 Exp. 1/6/2020,    10032559 Exp. 1/6/2020,    10032582 Exp. 1/6/2020,    10032809 Exp. 1/6/2020,  10032810 Exp. 1/6/2020, 10032811 Exp. 1/6/2020, 10032805 Exp. 1/5/2020, 10032805 Exp. 1/5/2020, 10032534 Exp. 1/14/2020, 10032534 Exp. 1/14/2020, 10032534 Exp. 1/14/2020, 10032534 Exp. 1/14/2020, 10032534 Exp. 1/14/2020, 10032534 Exp. 1/14/2020, 10031951 Exp. 12/26/2019, 10031951 Exp. 12/26/2019, 10031951 Exp. 12/26/2019, 10031951 Exp. 12/26/2019, 10033008 Exp. 1/15/2020, 10033008 Exp. 1/15/2020, 10032038 Exp. 1/19/2020, 10032038 Exp. 1/19/2020, 10032039 Exp. 1/19/2020, 10033008 Exp. 1/15/2020, 10032039 Exp. 1/19/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 500 mcg/250 mL (2 mcg/mL) Bupivacaine HCl 0.1% 250 mg/250 mL (1 mg/mL) in 0.9% Sodium Chloride 250 mL Bag, Rx only, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1160-37", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0546-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62664", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distribution was nationwide and to Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-102-2013", "product_description": "Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA", "product_quantity": "1,924,133/75-mcg. tablets", "reason_for_recall": "Subpotent; 9-month stability interval", "recall_initiation_date": "20120725", "center_classification_date": "20121221", "termination_date": "20131114", "report_date": "20130102", "code_info": "Lot HF23111"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82941", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1329-2019", "product_description": "Nandrolone Decanoate 200 mg/mL Injectable, 10 mL vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846", "product_quantity": "50 vials", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20190523", "center_classification_date": "20190607", "termination_date": "20210205", "report_date": "20190619", "code_info": "Lot #: 01312019:34 Exp. 07/30/2019"}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of assurance of sterility: Product bags leaking at seam.", "address_2": "", "product_quantity": "100 bags", "code_info": "LOT # 20170508@59, Use By: 08/06/17", "center_classification_date": "20170531", "distribution_pattern": "Nationwide in the USA", "state": "AR", "product_description": "fentaNYL (as citrate) in 100mL 0.9% Sodium Chloride injectable,20 mcg per mL, Single Dose Container bag, (Total fentanyl Dose 2,000 mcg/100 mL) Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-203-32", "report_date": "20170607", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0874-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77314", "termination_date": "20180329", "more_code_info": "", "recall_initiation_date": "20170518", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["BERKLEY JENSEN ALLERGY RELIEF"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["BJWC"], "product_ndc": ["68391-847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["d5b2dbed-76f0-45d4-9056-cf275ba0f94e"], "spl_set_id": ["2c6d9f8c-bc74-4e1a-bd51-50f84ab63a15"], "package_ndc": ["68391-847-47"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0901-2023", "product_description": "Non-Drowsy Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 150-count cartons, Distributed By: BJ's Wholesale Club, 25 Research Drive, Westborough, MA 01581.  NDC 68391-847-47", "product_quantity": "23,868 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #:2DV1863, 2HV2698, Exp. date 12/23; 2GV1583, Exp. date 02/24; 2GV1950, 2HV2697, Exp. Date 01/24.", "more_code_info": ""}, {"status": "Terminated", "city": "Wilmington", "state": "DE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90659", "recalling_firm": "Ultra Supplement LLC", "address_1": "1007 N Market St", "address_2": "N/A", "postal_code": "19801-1227", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.", "recall_number": "D-1350-2022", "product_description": "SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.", "product_quantity": "750 cartons", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.", "recall_initiation_date": "20220721", "center_classification_date": "20220817", "termination_date": "20231016", "report_date": "20220810", "code_info": "Lot DAP272109, Exp: 4/1/2026"}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0057-2025", "product_description": "Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01", "product_quantity": "3139 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0050, exp. date 04/25/2026; 24A0055, exp. date 05/09/2026; 24A0059, exp. date 05/16/2026; 24A0060, exp. date 05/20/2026; 24A0071, exp. date 06/24/2026; 24A0072, exp. date 06/26/2026"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74742", "recalling_firm": "GlaxoSmithKline, LLC", "address_1": "1011 N Arendell Ave", "address_2": "N/A", "postal_code": "27597-2309", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR.", "recall_number": "D-1443-2016", "product_description": "Bactroban Cream, (Mupirocin Calcium Cream 2%), 30 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in England, NDC 0029-1527-25,", "product_quantity": "7,480 tubes", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20160718", "center_classification_date": "20160720", "termination_date": "20170809", "report_date": "20160727", "code_info": "Lot #: C740906, Exp. Feb 2017.", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0285-2020", "product_description": "S-TEST CYP 200MG/ML MDV IN ETHYL OLEATE OIL, Rx only, a) 5ml, b) 10 ml, c) 13ml glass vials, Red Mountain Compounding Rx.", "product_quantity": "559 x 5, 10, 13 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S02072019DT@08, EXP 9/7/19; S02132019DH@06, Exp 8/13/19;   S02232019DH@06 Exp 8/23/19; S02282019DH@07 Exp 8/28/19;    S02252019DH@01 Exp 8/25/19; S02122019DH@06 Exp 8/12/19;  S03132019DT@02  Exp 9/13/19;03202019DT@01 Exp  9/20/19;   S03282019DT@05  Exp 9/28/19   S03212019DT@01  Exp 9/21/19   S04202019DT@03  Exp 10/20/19   S0412019DT@03  Exp 10/10/19   S04102019DT@12 Exp 10/10/19   S04232019DT@02 Exp 10/23/19   S03132019DT@03 Exp 9/13/19   S04232019DT@05 Exp 10/23/19   S05072019DT@07 Exp 11/7/19  S05242019DT@04 Exp 11/24/19   S06032019DT@06 Exp 12/3/19  S06182019DH@23 Exp 12/18/19  S06182019DH@22 Exp 12/18/19; S06252019DH@15, Exp 12/25/19   S06182019DH@24 Exp 12/18/19   S06262019DH@15 Exp 12/26/19   S07032019DT@03 Exp 1/3/20   S07132019DH@02 Exp 1/13/20   S07232019DH@11 Exp /23/20   S07182019DT@09 Exp 1/18/20   S07292019DH@02 Exp 1/29/20   S07312019DH@10 Exp 1/31/20  S05072019DT@07 Exp, 9/30/19  S06182019DH@23 Exp,11/30/19"}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80053", "recalling_firm": "RIJ Pharmaceutical LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0848-2018", "product_description": "GeriCare Senna Syrup (Sennosides 8.8 mg), 8 fl oz (237 mL) bottles, Dist, by Gericare Pharmaceuticals 1650 63rd Street  Brooklyn, NY 11204, NDC 57696-452-08, UPC 357896452087", "product_quantity": "21213 bottles", "reason_for_recall": "CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.", "recall_initiation_date": "20180507", "center_classification_date": "20180608", "termination_date": "20230407", "report_date": "20180620", "code_info": "Lot #: 47070082, 47070043, 47070011, Exp. 09/18"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0921-2022", "product_description": "Calcium Chloride 10% (100 mg/mL), Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835 NDC 73198-0064-30", "product_quantity": "5443 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: B24C21-22 BUD: 8/21/2022, B24B21-22 BUD: 8/21/2022, A24010-22 BUD: 7/10/2022, A24110-22 BUD: 7/10/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1099-2017", "product_description": "Beautipharm Eye Care Balm SPF 10 (Octocrylene 4% and Octyl methoxycinnamide 4%) Eye cream, 1 oz. Net. Wt. 30 ml bottle, Art. 03190 Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany. UPC 4 035219 031909.", "product_quantity": "73 balms", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 280318, Exp 03/28/2018; 020918, Exp 09/02/2018; 131019, Exp 10/13/19"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020125"], "brand_name": ["ACCURETIC"], "generic_name": ["QUINAPRIL AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-3112", "0071-0223", "0071-5212", "0071-7225"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "QUINAPRIL HYDROCHLORIDE"], "rxcui": ["310796", "310797", "310809", "809854", "809858", "882559"], "spl_id": ["489727cb-429e-4f04-a973-ae4dc7898519"], "spl_set_id": ["80e9d61d-9674-4ac4-b84c-79a875d408dd"], "package_ndc": ["0071-0223-23", "0071-3112-23", "0071-5212-23", "0071-7225-23"], "is_original_packager": [true], "upc": ["0300717225230", "0300713112237", "0300710223233", "0300715212232"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "33067B3N2M"]}, "product_type": "Drugs", "event_id": "89864", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0757-2022", "product_description": "Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/25 mg, 90 tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany,  NDC 0071-0223-23.", "product_quantity": "265 bottles", "reason_for_recall": "CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.", "recall_initiation_date": "20220321", "center_classification_date": "20220406", "termination_date": "20240828", "report_date": "20220413", "code_info": "Lot ET6974; Exp. 02/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0208-2016", "product_description": "BIEST TD 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3) VAN CR (vanishing cream) W/V (weight/volume) (4812) 2.5MG/ML Transdermal cream, dispensed in a) 1mL and b)3 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "1(1mL) syringe, 56 (3mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "a) Lot # 12292014:90@21, Exp 6/27/2015;  b) Lot # 02032015:55@13, Exp 8/2/2015"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["INFANTS PAIN AND FEVER"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Kroger Company"], "product_ndc": ["30142-766"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["2a7339bd-2db6-45a5-bbe0-cf55df3154fd"], "spl_set_id": ["7dbe284a-c0d5-4ac4-8445-611610f3c0fb"], "package_ndc": ["30142-766-16"], "is_original_packager": [true], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0595-2022", "product_description": "Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL) per bottle, DISTRIBUTED BY THE KROGER CO., CINCINNATI, OHIO 45202.  NDC: 30142-766-16", "product_quantity": "1,296 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1CK1274, Exp 02/28/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"brand_name": ["OPIUM TINCTURE DEODORIZED"], "generic_name": ["MORPHINE"], "manufacturer_name": ["Edenbridge Pharmaceuticals, LLC"], "product_ndc": ["42799-217"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MORPHINE"], "rxcui": ["830196"], "spl_id": ["5b376952-010f-adfc-e053-2a91aa0ae464"], "spl_set_id": ["e2a5697a-cc41-4cf1-b3a8-59b0268740d7"], "package_ndc": ["42799-217-01", "42799-217-02"], "is_original_packager": [true], "upc": ["0342799217017", "0342799217024"], "nui": ["N0000175684", "N0000175690"], "pharm_class_moa": ["Full Opioid Agonists [MoA]"], "pharm_class_epc": ["Opioid Agonist [EPC]"], "unii": ["76I7G6D29C"]}, "product_type": "Drugs", "event_id": "93236", "recalling_firm": "Edenbridge Pharmaceuticals, LLC", "address_1": "1 Upper Pond Rd", "address_2": "Ste 250", "postal_code": "07054-1050", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0080-2024", "product_description": "Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 Fl oz) bottles, Rx only, Manufactured for: Edenbridge Pharmaceuticals, LLC Parsippany, NJ 07054, NDC 42799-217-01", "product_quantity": "4548 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20231020", "center_classification_date": "20231030", "termination_date": "20240816", "report_date": "20231108", "code_info": "Lot#: 23ZCP1, Exp. Date 02/22/2026;Lot #:23ZDR1, Exp. Date 03/09/2026"}, {"country": "United States", "city": "Sanford", "address_1": "2650 S Mellonville Ave", "reason_for_recall": "Subpotent Drug: the active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.", "address_2": "", "product_quantity": "8,808 bottles", "code_info": "Lot #: H110940, Exp 08/13", "center_classification_date": "20130621", "distribution_pattern": "Nationwide and Puerto Rico", "state": "FL", "product_description": "Derma-Smoothe/FS (fluocinolone acetonide) Topical Oil (SCALP OIL), 0.01 %, 118.28 mL (4 Fl. oz.) bottle, Rx only, Manufactured and Distributed by: Hill Dermaceuticals, Inc. SANFORD, FLORIDA 32773; NDC 28105-149-04.", "report_date": "20130703", "classification": "Class III", "openfda": {}, "recalling_firm": "Hill Dermaceuticals, Inc.", "recall_number": "D-610-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65434", "termination_date": "20130719", "more_code_info": "", "recall_initiation_date": "20130507", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "3 Bags", "code_info": "Compounded on 05/28/2015, Discard After: 06/11/2015", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "CEFEPIME 1gm / NS 50mL AccuFlo, Packaged in 50 mL Bags, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1184-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA017512"], "brand_name": ["DIANEAL LOW CALCIUM WITH DEXTROSE"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"], "manufacturer_name": ["Vantive US Healthcare LLC"], "product_ndc": ["0941-0409", "0941-0411", "0941-0413", "0941-0415", "0941-0457", "0941-0459", "0941-0426", "0941-0427", "0941-0429", "0941-0424", "0941-0430", "0941-0433", "0941-0484", "0941-0487", "0941-0490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["799999", "800003", "800057", "800061", "800062", "800064", "800066", "800074", "800111", "800115", "800472", "800474"], "spl_id": ["36ea94f6-f614-9531-e063-6294a90aae55"], "spl_set_id": ["aa268d3f-7389-4f25-801f-5d4825495f08"], "package_ndc": ["0941-0411-05", "0941-0411-06", "0941-0411-07", "0941-0411-04", "0941-0411-11", "0941-0413-05", "0941-0413-06", "0941-0413-07", "0941-0413-01", "0941-0413-04", "0941-0415-05", "0941-0415-06", "0941-0415-04", "0941-0415-07", "0941-0415-01", "0941-0409-06", "0941-0409-05", "0941-0409-07", "0941-0409-01", "0941-0457-08", "0941-0457-02", "0941-0457-05", "0941-0457-01", "0941-0459-08", "0941-0459-02", "0941-0459-05", "0941-0459-01", "0941-0426-52", "0941-0426-53", "0941-0426-55", "0941-0427-52", "0941-0427-53", "0941-0427-55", "0941-0429-52", "0941-0429-53", "0941-0429-55", "0941-0424-51", "0941-0424-52", "0941-0424-53", "0941-0424-55", "0941-0430-51", "0941-0430-52", "0941-0430-53", "0941-0430-55", "0941-0433-51", "0941-0433-52", "0941-0433-53", "0941-0433-55", "0941-0484-01", "0941-0487-01", "0941-0490-01"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "67608", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1276-2014", "product_description": "Dianeal PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose, 6000 mL Ambu-Flex II container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code L5B9710, NDC 0941-0411-11", "product_quantity": "27,169 containers", "reason_for_recall": "Non-Sterility: Complaints of leaks and particulate matter identified as mold in the solution bag and the overpouch.", "recall_initiation_date": "20140211", "center_classification_date": "20140425", "termination_date": "20150722", "report_date": "20140507", "code_info": "Lot number: C903799, Exp 05/15", "more_code_info": ""}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1090-2019", "product_description": "PAPAVERINE-PHENTOLAMINE-PGE1 22-0.8 MG-8 MCG/ML* INJECTABLE, (a) 5ml (b) 10ml, (c) 6ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330", "product_quantity": "64 prescriptions 5, 10, 6 mL injections", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lot: (a) 18092018@52, 01102018@9, 05102018@36, 08102018@11, 102018@9, 01102018@9, 01102018@9, 03102018@27, 12102018@18, 01102018@9, 12102018@18, 12102018@18, 17102018@15, 12102018@18, 2102018@18, 22102018@31,  30102018@22, 29102018@9,29102018@9  29102018@9, 29102018@9, 12102018@18, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 11122018@7, 11122018@7, 28122018@11, 28122018@11, 28122018@11, 03012019@17, 03012019@17, 03012019@17, 08012019@21, 08012019@21,28082018@16  28082018@16, 28082018@16, 14092018@28, 14092018@28, 4092018@28, 14092018@28,  18092018@52, 18092018@52, 8092018@52, 18092018@52, 18092018@52, (b) 29102018@9, 03012019@17,14092018@28, (c) 11012019@64, 11012019@64, 11012019@64, 05022019@27, 5022019@27, 06022019@6, 06022019@6, distributed between 09-01-2018 to 02-20-2019."}, {"status": "Terminated", "city": "Glendora", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72517", "recalling_firm": "Oasis Medical, Inc.", "address_1": "514 S. Vermont Ave Bldg 510-528", "address_2": "N/A", "postal_code": "91741-6205", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Saudi Arabia, Israel, Chile, Norway, Ecuador, Greece, Switzerland, Canada, England, Columbia, Poland, South Africa, Germany, Pakistan, El Salvador, Dubai, Belgium", "recall_number": "D-0522-2016", "product_description": "HPMC Visoelastic, 20,000 cps, Reference 5122, 515 (Private Label), 600102-001 (Private Label), 600103-001 (Private Label), 2.0 mL in 3-mL Syringe, OASIS Medical Inc, 514 South Vermont Avenue Glendora, CA 91741", "product_quantity": "15,301 units", "reason_for_recall": "Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.", "recall_initiation_date": "20151019", "center_classification_date": "20151222", "termination_date": "20160314", "report_date": "20151230", "code_info": "Lot #: V0814H, V0814J, Exp 08/2016;  V1014L, Exp 11/2016;  V1114A, Exp 11/2016; V0115G, V0115H, Exp 01/2017; V0215A, V0215B, Exp 02/2017; V0315G, V0315H, V0315O, Exp 03/2017; V0515C, V0515D, Exp 05/2017."}, {"country": "United States", "city": "Tulsa", "address_1": "6136 E 51st St", "reason_for_recall": "Lack of Assurance of Sterility: concerns of sterility assurance with the  pharmacy's independent testing laboratory.", "address_2": "", "product_quantity": "3540 mL", "code_info": "Lot 05022013@20, Exp 10/29/13", "center_classification_date": "20131003", "distribution_pattern": "Oklahoma", "state": "OK", "product_description": "Estradiol 1.25 mg, Progesterone 25 mg/mL injectable, 20 mL sterile vials, The Apothecary Shoppe, 6136 E. 51st St. Tulsa, OK 74135.", "report_date": "20131009", "classification": "Class II", "openfda": {}, "recalling_firm": "Apothecary Shoppe", "recall_number": "D-66241-001", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66241", "termination_date": "20160208", "more_code_info": "", "recall_initiation_date": "20130906", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-240-2014", "product_description": "Mic Ultra-Sulfur Free 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0238-2025", "product_description": "Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-755-01.", "product_quantity": "120,000 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers:  19232356, Exp.: 5/2025; 19233198, Exp.: 7/2025; 19234213, 19234232, Exp.: 9/2025; 19241445, Exp.: 3/2026; 19243033, 19243121, Exp.: 7/2026."}, {"status": "Terminated", "city": "Rochelle Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040907"], "brand_name": ["HYDROCHLOROTHIAZIDE"], "generic_name": ["HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "product_ndc": ["29300-128", "29300-129", "29300-485"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE"], "rxcui": ["197770", "310798", "429503"], "spl_id": ["1e92de42-a7f2-4674-8260-28cfabf0759d"], "spl_set_id": ["33f3b980-b339-4dbf-99bd-05588c2a298c"], "package_ndc": ["29300-128-01", "29300-128-05", "29300-128-10", "29300-128-50", "29300-129-01", "29300-129-05", "29300-129-10", "29300-129-50", "29300-485-01", "29300-485-10"], "is_original_packager": [true], "upc": ["0329300129014", "0329300128017"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH"]}, "product_type": "Drugs", "event_id": "71860", "recalling_firm": "Unichem Pharmaceuticals Usa Inc", "address_1": "201 W Passaic St Ste 403", "address_2": "N/A", "postal_code": "07662-3128", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1352-2015", "product_description": "Hydrochlorothiazide Tablet USP 25 mg,1000- count bottle, Rx Only,  Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Marketed by: UNICHEM PHARMACEUTICALS (USA), INC. Rochelle Park, NJ 07662, NDC 29300-128-10", "product_quantity": "4776 bottles", "reason_for_recall": "Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in  the 1000-count bottle of hydrochlorothiazide 25 mg tablets.", "recall_initiation_date": "20150730", "center_classification_date": "20150825", "termination_date": "20181019", "report_date": "20150902", "code_info": "Lot #: GHYL15028, Exp April 2018"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "8 ml", "code_info": "All lots distributed between November 2014 and May 2015;  04142015@61, 10/11/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix (10/0.174/16) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1761-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ASCORBIC ACID, Tablet, 500 mg may have potentially been mislabeled as the following drug:  OXcarbazepine, Tablet, 150 mg, NDC 62756018388, Pedigree: AD54562_4, EXP: 5/20/2014.", "address_2": "", "product_quantity": "2018 Tablets", "code_info": "ASCORBIC ACID, Tablet, 500 mg has the following codes:   Pedigree: AD54576_4, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASCORBIC ACID, Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052380.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1020-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020971"], "brand_name": ["ARTICADENT"], "generic_name": ["ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Dentsply Pharmaceutical"], "product_ndc": ["66312-601", "66312-602"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBMUCOSAL"], "substance_name": ["ARTICAINE HYDROCHLORIDE", "EPINEPHRINE BITARTRATE"], "rxcui": ["1011646", "1011648", "1595029", "1595035"], "spl_id": ["7b56ec0a-5b85-4069-a3b2-94654644aaa4"], "spl_set_id": ["9ca8fb43-4f34-47c0-8b79-3b5bd1eaee00"], "package_ndc": ["66312-601-16", "66312-602-16"], "is_original_packager": [true], "upc": ["0000004235644"], "unii": ["QS9014Q792", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "82760", "recalling_firm": "Septodont Inc.", "address_1": "416 S Taylor Ave", "address_2": "N/A", "postal_code": "80027-3028", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1307-2019", "product_description": "Articaine DENTAL, Articane hydrochloride 4% and epinephrine 1:100,000,   50 cartridges. 1.7 mL each, Rx only, Manufactured for: DENTSPLY Pharmaceutical, by Novocol Pharmaceutical of Canada, Inc. York, PA 17404, NDC 66312-601-16 Reorder #: 51116", "product_quantity": "240 cartons of 50 glass cartridges each", "reason_for_recall": "Labeling: Not Elsewhere Classified. This recall has been initiated due to mislabeling. The printed carton used in manufacturing both batches contained text for both 2% Xylocaine DENTAL and Articadent DENTAL. Xylocaine DENTAL is a trade name for Lidocaine HCL 2% and Epinephrine 1: 100,000 formulation, while Articadent DENTAL is a trade name for Articaine HCI 4% and Epinephrine 1 :100,000. The cartridges contained within the  printed carton are labeled appropriately as Articadent DENTAL.", "recall_initiation_date": "20190502", "center_classification_date": "20190528", "termination_date": "20201119", "report_date": "20190529", "code_info": "Lot # D02599A, exp. Sept 2020, D02608B, exp. October 2020"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; IBUPROFEN, Tablet, 400 mg may be potentially mislabeled as    ASPIRIN, Tablet, 325 mg, NDC 00536330501, Pedigree: W002573, EXP: 6/3/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "IBUPROFEN, Tablet, 400 mg has the following code    Pedigree: W002577, EXP: 6/3/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "IBUPROFEN, Tablet, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 67877029401", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-723-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83025", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1389-2019", "product_description": "Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/  Extended-Release Tablets, USP, Allergy & Congestion, 30-count box. Distributed by: Walgreen Co. 200 Wilmore Rd. Deerfield, IL 40015. Made in India.  UPC 3 11917 19454 7", "product_quantity": "14,399 30-count units", "reason_for_recall": "Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit", "recall_initiation_date": "20190605", "center_classification_date": "20190614", "termination_date": "20210108", "report_date": "20190626", "code_info": "Lot: GKS1014, EXP 09/2019; GKT0484A, EXP 04/2020"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0062-2019", "product_description": "Well at Walgreens, ULTRA FINE Sinus Relief Mist (Oxymetazoline HCl 0.05%) bottle, Sinus Reliever, Nasal Decongestant, 12 Hour Pump Mist, 0.5 FL OZ (15 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-7000-01, UPC 3 11917 18535 4.", "product_quantity": "361,104 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}]